Stress, catecholaminergic system and cancer.
O Krizanova1,2, P Babula2, K Pacak3
1a Institute of Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences , Bratislava , Slovakia ;
Stress (Amsterdam, Netherlands)
|July 12, 2016
Summary
Chronic stress negatively impacts health and cancer treatment. Beta-blockers, used for heart conditions and anxiety, may lower cancer rates by counteracting stress hormones.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Chronic stress detrimentally affects health and can impair cancer treatments.
- Physical stressors like cold exposure can reduce chemotherapy efficacy and anti-tumor immunity.
- Epidemiological studies link beta-blocker use to reduced incidence of several cancers.
Purpose of the Study:
- To review the role of catecholamines (stress hormones) in cancer development.
- To explore the potential of beta-blockers as anti-cancer therapeutic agents.
Main Methods:
- Literature review of stress hormones, tumorigenesis, and beta-blocker effects.
- Analysis of epidemiological data on beta-blocker use and cancer rates.
- Synthesis of current knowledge on catecholamines in cancer biology.
Main Results:
- Catecholamines, as key stress hormones, play a significant role in tumorigenesis.
- Beta-blockers show promise in potentially reducing cancer incidence.
- Evidence suggests a link between stress, catecholamines, and impaired anti-tumor responses.
Conclusions:
- Beta-blockers represent a potential therapeutic strategy for cancer prevention and treatment.
- Targeting stress pathways could offer novel approaches in oncology.
- Further research is warranted to elucidate the mechanisms of beta-blockers in cancer.
Related Concept Videos
01:27Adrenergic Neurons: Neurotransmission
5.7K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
5.7K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
01:31Sympathetic Signaling
3.0K
Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
3.0K
01:25Adrenergic Agonists: Indirect-Acting Agents
3.0K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
3.0K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.7K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.7K
01:16Sympathetic Activation
8.1K
The sympathetic division can influence tissues and organs by releasing norepinephrine at peripheral synapses and distributing epinephrine and norepinephrine through the bloodstream. In times of crisis or stress, sympathetic activation occurs, which is regulated by sympathetic centers in the hypothalamus. As a result, sympathetic activation prepares the body for physical exertion, rapid ATP production, and heightened alertness, allowing individuals to respond effectively to challenging or...
8.1K